儿童急性淋巴细胞白血病(ALL)的治疗已有一定进展,但某些类型仍有高度复发的危险性。已知1岁以下婴儿白血病治疗多数失败,部分反映了其独特的临床生物学特性。不仅骨髓与中枢神经系统(CNS)的ALL有高度复发危险,年龄小也使其对治疗远期效应和神经心理毒性易感。本文报告了1岁 There has been some progress in the treatment of childhood acute lymphoblastic leukemia (ALL), but some types are still at high risk for relapse. It is known that the majority of infantile leukemias below 1 year old have failed and partly reflect their unique clinical biological characteristics. Not only are there a high risk of recurrence of ALL in the bone marrow and central nervous system (CNS), but younger age makes it susceptible to long-term effects and neuropsychological toxicities. This article reports on 1 year old